Dra Consultants Ltd vs Ep Biocomposites Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Mar 13, 2026

Key Highlights

The Latest Trading Price of DRA Consultants Ltd is ₹ 15.36 as of 12 Mar 15:30 . The P/E Ratio of DRA Consultants Ltd changed from 6.2 on March 2021 to 10.1 on March 2025 . This represents a CAGR of 10.25% over 5 yearsThe P/E Ratio of EP Biocomposites Ltd changed from 58.8 on March 2023 to 20.1 on March 2025 . This represents a CAGR of -30.08% over 3 years The Market Cap of DRA Consultants Ltd changed from ₹ 9.98 crore on March 2021 to ₹ 27.27 crore on March 2025 . This represents a CAGR of 22.27% over 5 yearsThe Market Cap of EP Biocomposites Ltd changed from ₹ 33.88 crore on March 2023 to ₹ 20.75 crore on March 2025 . This represents a CAGR of -15.08% over 3 years The Dividend Payout of DRA Consultants Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of EP Biocomposites Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About DRA Consultants Ltd

DRA Consultants Limited was originally incorporated in Mumbai, as a proprietary firm in the year 1990, under the name and style of Dinesh Rathi and Associates.
Thereafter, a Company was formed by the Promoters, Dinesh Rathi and Uma Rathi, under the name and style of 'DRA Consultants Private Limited', on May 5, 2009, issued by Assistant Registrar of Companies.
Thereafter, Company acquired business of proprietary firm vide agreement dated June 30, 2009.
Subsequently, it converted into Public Limited Company, and the name was changed to 'DRA Consultants Limited'.
A fresh Certificate of Incorporation upon conversion from Private company to Public Company dated August 24, 2016, was issued by the Registrar of Companies. The Company is engaged mainly in the business of engineering consultancy in India.

About EP Biocomposites Ltd

EP Biocomposites Limited was incorporated as Public Limited Company on January 17, 2020 with the Registrar of Companies, Goa.
Further, pursuant to Business Takeover Agreement dated August 31, 2021, the Company took over the running business of M/s.
OM Ventures, a proprietorship concern through one of its Promoter Leena Kamat.
In September 2022, Company made an Initial Public Offer of 5,04,000 Equity Shares of Rs 10 each by raising funds aggregating to Rs. 6.35 Crore. The Company is involved in manufacturing and supplying of a vast portfolio of products and services, which includes Fibre Glass doors and allied products, Bio Digester Toilets with DRDO technology and actively contributing to wastewater recycling through its solution in Sewage Treatment Plants (STP)and Effluent Treatment Plants (ETP).

FAQs for the comparison of DRA Consultants Ltd and EP Biocomposites Ltd

Which company has a larger market capitalization, DRA Consultants Ltd or EP Biocomposites Ltd?

Market cap of DRA Consultants Ltd is 16 Cr while Market cap of EP Biocomposites Ltd is 16 Cr

What are the key factors driving the stock performance of DRA Consultants Ltd and EP Biocomposites Ltd?

The stock performance of DRA Consultants Ltd and EP Biocomposites Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for DRA Consultants Ltd and EP Biocomposites Ltd?

As of March 13, 2026, the DRA Consultants Ltd stock price is INR ₹15.36. On the other hand, EP Biocomposites Ltd stock price is INR ₹99.1.

How do dividend payouts of DRA Consultants Ltd and EP Biocomposites Ltd compare?

To compare the dividend payouts of DRA Consultants Ltd and EP Biocomposites Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.